Zum Inhalt springen

Jeff Coller

@jmcoller.bsky.social did:plc:i74zljkbrbibk7txfptqqzd6

RNA Biologist - Bloomberg Distinguished Professor of mRNA Biology and Therapeutics. Director of the Hopkins RNA Innovation Center. Cofounder - Tevard Biosciences. Cofounder - Alliance for mRNA Medicines. Cofounder - Foundation for mRNA Medicines.

Bei Bluesky seit

Follower
926
Folgt
653
Posts
57
Tage in Ranglisten
0

Zusammenfassung

Jeff Coller (@jmcoller.bsky.social) ist seit 17 November 2024 auf Bluesky. Das Konto hat 926 Follower, folgt 653 Konten und hat 57 Posts veröffentlicht.

Ranglisten-Platzierungen

Die besten Tage, an denen Posts dieses Kontos in Debyas Tagesliste kamen.

Dieses Konto war noch in keiner Tagesrangliste.

Zuletzt gelikte Posts

Öffentliche Likes aus dem Bluesky-Netzwerk.

  • JHU Bloomberg Distinguished Professorships@jhu-bdps.bsky.social

    Join BDP @jmcoller.bsky.social as he moderates a panel on the future of medical treatment at the Future of Next event on November 10, at the Johns Hopkins University Bloomberg Center in Washington, DC. Learn more: web.cvent.com/event/3619b5...

    Post anzeigen
  • JHU Bloomberg Distinguished Professorships@jhu-bdps.bsky.social

    In a @nytimes.com op-ed, BDP @jmcoller.bsky.social urges the US to develop and maintain a system that can fight back against AI-designed biological threats. www.nytimes.com/2026/10/12/o...

    Post anzeigen
  • The New York Times@nytimes.com

    In @nytopinion.nytimes.com We need to “enable the biosecurity community to develop countermeasures — vaccines, antibodies, antivirals and diagnostics — at a speed we haven’t seen since the Covid-19 pandemic,” Jeff Coller writes.

    Post anzeigen
  • Jamie Cate@jhdcate.bsky.social

    A note on the proposed rule, "Regulation For Federal Financial Assistance," www.regulations.gov/document/OMB... I posted comments on Weds 6/17, and they just appeared today. Keep them coming!

    Post anzeigen
  • The New York Times@nytimes.com

    In Opinion The system that turned Gila monster venom into GLP-1 drugs is being dismantled through research budget cuts, Jeff Coller writes in a guest essay. “Less support for scientists means strange questions no one will get to chase. Exploring those questions is how medicine advances.”

    Post anzeigen

Melde dich an, um mehr zu sehen

Blockierte Konten

Blockierungen sind auf Bluesky öffentlich.